Skip to content

ANGIOTECH PHARMACEUTICALS INC

Delisted

CIK 1096481fmd_0BCR6XPK8QW65NDPMQG7K27RAFManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2011 to Dec 31, 2012, 8 periods

Latest annual · FY2012

Millions
Total revenues
244
Gross profit
141
Operating income
27
Free cash flow
64

Latest quarter · Q4 FY2012

Millions
Total revenues
65
Gross profit
38
Operating income
9
Free cash flow
27
Open Financials

ANGIOTECH PHARMACEUTICALS INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2012ChangeSource
Revenue$243.8 million10-K 2013-03-28 · proof
Gross profit$140.5 million10-K 2013-03-28 · proof
Operating income$26.8 million10-K 2013-03-28 · proof
Cash from operating activities$66.4 million10-K 2013-03-28 · proof
Free cash flow$64.3 million10-K 2013-03-28 · proof
Total assets$608.4 million10-K 2013-03-28 · proof
Total liabilities$467.7 million10-K 2013-03-28 · proof
Cash and cash equivalents$45.9 million10-K 2013-03-28 · proof
Total debt$289.4 million10-K 2013-03-28 · proof
What was ANGIOTECH PHARMACEUTICALS INC's revenue in fiscal 2012?
ANGIOTECH PHARMACEUTICALS INC reported revenue of $243.8 million for fiscal 2012 (the year ended Dec 31, 2012). Source: the 10-K filed with the SEC on Mar 28, 2013. SEC
What was ANGIOTECH PHARMACEUTICALS INC's gross profit in fiscal 2012?
ANGIOTECH PHARMACEUTICALS INC reported gross profit of $140.5 million for fiscal 2012 (the year ended Dec 31, 2012). Source: the 10-K filed with the SEC on Mar 28, 2013. SEC
What was ANGIOTECH PHARMACEUTICALS INC's operating income in fiscal 2012?
ANGIOTECH PHARMACEUTICALS INC reported operating income of $26.8 million for fiscal 2012 (the year ended Dec 31, 2012). Source: the 10-K filed with the SEC on Mar 28, 2013. SEC
What was ANGIOTECH PHARMACEUTICALS INC's cash from operating activities in fiscal 2012?
ANGIOTECH PHARMACEUTICALS INC reported cash from operating activities of $66.4 million for fiscal 2012 (the year ended Dec 31, 2012). Source: the 10-K filed with the SEC on Mar 28, 2013. SEC
What was ANGIOTECH PHARMACEUTICALS INC's free cash flow in fiscal 2012?
ANGIOTECH PHARMACEUTICALS INC reported free cash flow of $64.3 million for fiscal 2012 (the year ended Dec 31, 2012). Source: the 10-K filed with the SEC on Mar 28, 2013. SEC
What are ANGIOTECH PHARMACEUTICALS INC's total assets?
As of Dec 31, 2012, ANGIOTECH PHARMACEUTICALS INC reported total assets of $608.4 million. Source: the 10-K filed with the SEC on Mar 28, 2013. SEC
What are ANGIOTECH PHARMACEUTICALS INC's total liabilities?
As of Dec 31, 2012, ANGIOTECH PHARMACEUTICALS INC reported total liabilities of $467.7 million. Source: the 10-K filed with the SEC on Mar 28, 2013. SEC
What are ANGIOTECH PHARMACEUTICALS INC's cash and cash equivalents?
As of Dec 31, 2012, ANGIOTECH PHARMACEUTICALS INC reported cash and cash equivalents of $45.9 million. Source: the 10-K filed with the SEC on Mar 28, 2013. SEC
What is ANGIOTECH PHARMACEUTICALS INC's total debt?
As of Dec 31, 2012, ANGIOTECH PHARMACEUTICALS INC reported total debt of $289.4 million. Source: the 10-K filed with the SEC on Mar 28, 2013. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1096481&period_type=annual&limit=5"

Information only, not investment advice.